Countries citing papers authored by Fabio Malugani
Since
Specialization
Citations
This map shows the geographic impact of Fabio Malugani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Malugani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Malugani more than expected).
This network shows the impact of papers produced by Fabio Malugani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Malugani. The network helps show where Fabio Malugani may publish in the future.
Co-authorship network of co-authors of Fabio Malugani
This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Malugani.
A scholar is included among the top collaborators of Fabio Malugani based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Fabio Malugani. Fabio Malugani is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lissoni, Paolo, Massimo Vaghi, Franco Rovelli, et al.. (2005). Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia.. PubMed. 18(3-4). 291–4.8 indexed citations
3.
Lissoni, Paolo, Fabio Malugani, Antonio Ardizzoia, et al.. (2003). Psychooncology and cancer progression-related alterations of pleasure-associated neurochemical system: Abnormal neuroendocrine response to apomorphine in advanced cancer patients.. PubMed. 24(1-2). 50–3.4 indexed citations
Lissoni, Paolo, et al.. (2003). Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients.. PubMed. 24(1-2). 83–5.12 indexed citations
6.
Lissoni, P., Massimo Vaghi, A Ardizzoia, et al.. (2003). A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.. PubMed. 16(2). 93–6.22 indexed citations
7.
Lissoni, Paolo, Fabio Malugani, R Bucovec, et al.. (2002). Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.. PubMed. 15(2). 140–4.88 indexed citations
8.
Lissoni, P., Massimo Vaghi, Luca Fumagalli, et al.. (2002). Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.. PubMed. 22(2B). 1061–4.19 indexed citations
9.
Lissoni, Paolo, Elena Fumagalli, Fabio Malugani, et al.. (2002). Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients.. PubMed. 15(2). 163–5.3 indexed citations
10.
Lissoni, Paolo, et al.. (2002). A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone.. PubMed. 23(3). 255–8.16 indexed citations
11.
Lissoni, Paolo, et al.. (2002). Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.. PubMed. 23(1). 61–3.72 indexed citations
12.
Lissoni, Paolo, R Bucovec, Fabio Malugani, et al.. (2002). A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines.. PubMed. 22(2B). 1131–4.19 indexed citations
Lissoni, Paolo, F Brivio, Gabriele Fumagalli, et al.. (2001). Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease.. PubMed. 14(4). 275–7.33 indexed citations
15.
Viganò, Daniela, Paolo Lissoni, Franco Rovelli, et al.. (2001). A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia.. PubMed. 22(2). 137–41.42 indexed citations
16.
Lissoni, Paolo, Mario Mandalà, Luisa Giani, et al.. (2000). Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia.. PubMed. 21(5). 405–408.10 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.